Roche shares fall on modest 2024 outlook

Roche opens new tab shares fell more than 4% on Thursday as the market expressed disappointed with the company's more modest than expected 2024 outlook.
The Swiss drugs and diagnostic maker said on Thursday that group sales, which include diagnostics, would grow by a mid-single digit percentage, when adjusted for currency swings.